Resuming VYKAT™ XR Treatment Shows Significant Benefits for Prader-Willi Syndrome Patients, New Data Reveals

Soleno Therapeutics recently announced new findings regarding its investigational drug VYKAT™ XR (diazoxide choline extended-release tablets) for the treatment of Prader-Willi syndrome (PWS), as detailed at GlobeNewswire. The data, which…

Continue Reading Resuming VYKAT™ XR Treatment Shows Significant Benefits for Prader-Willi Syndrome Patients, New Data Reveals

Unseen and Underdiagnosed: Betrice’s Fight to Raise Awareness of Alpha-1 in the Black Community

Alpha-1 Antitrypsin Deficiency: According to the Alpha-1 Foundation, 1 in 1,500 to 3,500 people of European descent are affected by this rare genetic disease. Antitrypsin or A1AT is a plasma…

Continue Reading Unseen and Underdiagnosed: Betrice’s Fight to Raise Awareness of Alpha-1 in the Black Community